Comparative evaluation of USP II, USP IV, TIM-2, and the dynamic colon model as surrogates for human colonic drug dissolution.

This study compares conventional dissolution apparatuses (USP II and IV) with advanced biorelevant models (TIM-2 and the Dynamic Colon Model, DCM) for assessing colonic drug dissolution. Theophylline dissolution from modified-release Uniphyllin Continus® tablets was evaluated across varying hydrodynamic conditions, with the DCM serving as a physiologically validated benchmark. Dissolution was highly dependent on USP II paddle speed (50-200 rpm). In the USP IV increasing flow rate (4-50 mL min-1) increased 24 h dissolution but had relatively low impact at 1-5 h. In both systems, the lowest agitation conditions (50 rpm and 4 mL min-1) provided the closest agreement to DCM profiles. A simplified TIM-2 configuration was used to isolate hydrodynamic effects, demonstrating motility-dependent release, with slower mixing producing dissolution profiles most similar to the DCM. Incorporation of dewatering improved agreement with the stimulated DCM condition for all systems. The consistent trend across systems of improving similarity to the DCM data with decreasing agitation suggests that conditions below the ranges tested here may be warranted in future studies. USP II and USP IV remain practical and robust tools for quality control but TIM-2 and the DCM better replicate colonic hydrodynamics. TIM-2, even in its simplified configuration in this study, offers additional capability to modulate peristaltic motility patterns and provides a promising platform into which the standard TIM colonic fluids, secretion and absorption functions, can be progressively reintroduced to improve biopredictivity. These findings highlight the complementary role of conventional and advanced dissolution approaches and support integrating physiologically relevant parameters into dissolution testing frameworks to improve biopredictive assessment for modified release formulations.